Eltrombopag monotherapy can improve hematopoiesis in patients with low to intermediate risk-1 myelodysplastic syndrome
艾曲波帕单药治疗可改善低危至中危-1型骨髓增生异常综合征患者的造血功能。
期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2020.249995
Vicente, Alana; Patel, Bhavisha A; Gutierrez-Rodrigues, Fernanda; Groarke, Emma; Giudice, Valentina; Lotter, Jennifer; Feng, Xingmin; Kajigaya, Sachiko; Weinstein, Barbara; Barranta, Evette; Olnes, Matthew J; Parikh, Ankur R; Albitar, Maher; Wu, Colin O; Shalhoub, Ruba; Calvo, Katherine R; Townsley, Danielle M; Scheinberg, Phillip; Dunbar, Cynthia E; Young, Neal S; Winkler, Thomas